Screen for multiple cancers now with the Galleri® test

Take control when it comes to cancer. The Galleri test helps you be proactive about your health.1

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test should be used in addition to cancer screening tests your healthcare provider recommends. Galleri is by prescription only.

Galleri Lifestyle Shot08 4163

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test should be used in addition to cancer screening tests your healthcare provider recommends. Galleri is by prescription only.

Start screening before symptoms appear

Galleri is a screening test that looks for cancer before symptoms appear, when cancer may be easier to treat. It is important to get cancer screenings even if you feel fine.

12 of the deadliest cancers are responsible for two-thirds of cancer deaths. These cancers tend to release more DNA fragments into the bloodstream at early stages.

The Galleri test screens for many of these deadly cancers that have no recommended screening tests.

The Galleri test sensitivity for these cancers varies across cancer types and stages.

12 cancer image

How the Galleri test works

Cancers growing in the body shed DNA into the bloodstream.1,2,3 Although there are many types of cancer, the DNA fragments can act like a unique “fingerprint” of cancer. This Galleri test screens for many of the deadliest cancers before they become symptomatic,4 including many without recommended screening tests.1,5 The Galleri test results provide direction to your healthcare provider and help guide the next steps for diagnosis.4

Watch a short video on how the Galleri test works

Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.

illustrated graphic video explaining how the Galleri test works

Healthy holidays!

This season, prioritize health for yourself and your loved ones by screening for multiple cancers with the Galleri test. For a limited time, receive $50 off.*

The Galleri test is available by prescription only. This offer is available through your provider or tests can be requested online at Galleri.com through an independent telemedicine provider. You must be 50 or older to take advantage of the online offer. Eligibility will be assessed at the time of your test request. The discount only applies to full-priced, self-pay tests priced at $949. Most health insurance plans do not cover the Galleri test.

Use the Galleri Key "24GIFT50" when you request the test.

Limited time offer valid only for Galleri test orders placed November 28, 2024, midnight PST through the applicable Offer End Date (defined below). Valid only for Galleri test orders requested online and approved by the GRAIL-contracted independent telemedicine provider (“Telemedicine Order”) or by your independent healthcare provider using the GRAIL-provided Test Requisition Form specifically for this offer (“Clinic Order”). The “Offer End Date” means: (i) for Telemedicine Orders, December 31, 2024, 11:59 pm PST; (ii) for Clinic Orders, January 31, 2025, 11:59 pm PST. Valid for Clinic Orders only if the blood draw for the Galleri test is completed by the applicable Offer End Date. Offer does not confirm your eligibility for the Galleri test. Valid only for one-time use on domestic US Galleri test orders only. Offer valid only for a discount off the Galleri test list price ($949). Offer cannot be: (1) combined or used with any other discount, promotion, special pricing, or payment plan; (2) used to request a credit on a test order placed prior to the offer period; or (3) posted online or on any other publicly available forum. GRAIL reserves the right to change the terms and conditions, substitute an offer of equal or greater value, and end the offer at any time without notice. For Galleri test orders requested online, you must create an account to redeem this offer and enter the code at the “Introduction” stage, where prompted.

Healthy Holidays

Our testing process

illustrated graphic of a Black male doctor in a white lab coat reading a chart

1. Request the test

The Galleri test is available by prescription only. Your healthcare provider can order the test, or you can request it through our website from an independent telemedicine provider.

illustrated graphic of a white, gray haired female patient having her blood drawn

2. Blood Draw

Complete your blood draw at your doctor’s office
OR
Schedule your blood draw with one of our partners. There are two options:
1. Have a trained technician come to you. 
2. Visit a partner lab location near you.

Illustrated graphic of a black man sitting in a blue armchair and reviewing test results on a tablet

3. Receive your test result

Your test result will be available about two weeks after your sample is received at the GRAIL lab.

Understanding your Galleri test result

You will receive your test result about two weeks after your blood sample is received at the GRAIL lab.

There are two possible results:

  • No Cancer Signal Detected
  • Cancer Signal Detected

Nearly 99% of people who use the Galleri test, will screen negative — which is exactly what you want to hear.4 Continue with routine cancer screening tests your healthcare provider recommends.

If a cancer signal is found, results can predict the tissue type or organ associated with the cancer signal and help your healthcare provider guide the next steps.4

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur.

pink square graphic with an exclamation mark icon in the upper right corner with the text "cancer signal detected" in the bottom left corner, overlapping a blue square graphic with a check mark icon in the upper right corner with the test "no cancer signal detected" in the bottom left corner

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.

  1. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021 Sep;32(9):1167-77. doi: 10.1016/j.annonc.2021.05.806

  2. Liu MC, Oxnard GR, Klein EA, et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020 Mar 30;31(6):745-59. doi: 10.1016/j.annonc.2020.02.011

  3. Thierry AR, El Messaoudi S, Gahan PB, et al. Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev. 2016 Jul 8;35:347–76. doi: 10.1007/s10555-016-9629-x

  4. Schrag D, Beer TM, McDonnell CH, et al. Blood-based tests for multi-cancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402:1251-1260. doi: 10.1016/S0140-6736(23)01700-2

  5. US Preventive Services Task Force. A,B,C grade recommendations, cancer, screenings. [cited 2023 Oct 23]. https://www.uspreventiveservicestaskforce.org/uspstf/topic_search_results